SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-165839
Filing Date
2017-05-10
Accepted
2017-05-10 16:06:06
Documents
7
Period of Report
2017-06-21
Effectiveness Date
2017-05-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d309527ddef14a.htm DEF 14A 323965
2 GRAPHIC g309527g0503022813597.jpg GRAPHIC 3274
3 GRAPHIC g309527g35g96.jpg GRAPHIC 31248
4 GRAPHIC g309527g92c79.jpg GRAPHIC 2003
5 GRAPHIC g309527jpg00001.jpg GRAPHIC 5139
6 GRAPHIC g309527pc01.jpg GRAPHIC 14171
7 GRAPHIC g309527pc02.jpg GRAPHIC 14218
  Complete submission text file 0001193125-17-165839.txt   421760
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36279 | Film No.: 17830223
SIC: 2834 Pharmaceutical Preparations